AMOXAPINE

Amoxapine is a tetracyclic antidepressant with dopamine-blocking effects, useful in depressive disorders. Side effects include drowsiness, dry mouth, and extrapyramidal symptoms.

SKU: 0c20d91ee40c Category: Tag:

Product Description


Mechanism of action

Amoxapine is a tetracyclic antidepressant with dual action: inhibition of norepinephrine reuptake and partial antagonism at dopamine D₂ receptors. The dopamine antagonism confers mild antipsychotic activity. It also displays antagonistic effects at 5‑HT₂, α₁-adrenergic and histamine receptors.

Benefits and advantages

Used in research addressing depressive disorders with psychotic features, dopaminergic modulation and receptor cross‑talk. Its hybrid antidepressant–antipsychotic profile makes it important for comparative mood disorder studies.

Side effects and risks

Risk of seizures, extrapyramidal symptoms, arrhythmias and anticholinergic side effects. Appropriate containment measures are required.

Datasheet


Molecular Formula

C17H16ClN3O

Molecular Weight

313.8 g/mol

CAS Number

14028-44-5

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

1.71e-01 g/L

Purity

Purity information is available upon request (COA).

Synonym

amoxapine; 14028-44-5; Asendin; Demolox; Amoxan

IUPAC/Chemical Name

8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine

InChl Key

QWGDMFLQWFTERH-UHFFFAOYSA-N

InChl Code

InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2

References

https://pubchem.ncbi.nlm.nih.gov/compound/2170;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download